Innovating Hope: Building Breakthrough Biotech Companies with Rami Elghandour of Arcellx (NASDAQ: ACLX)

​Series Seed is hosting a virtual conversation with Rami Elghandour, Chairman & CEO of Arcellx (NASDAQ: ACLX), a clinical-stage biotechnology company developing transformative immunotherapies for cancer. From designing implantable neurostimulators as an engineer, to leading venture investments at Johnson & Johnson, to building two multibillion-dollar public companies, Nevro and Arcellx, Rami's career is a masterclass in reinvention, conviction, and building at the intersection of science and business.

​This session will explore what it takes to identify breakthrough science and turn it into a company worth billions, how to navigate career pivots across engineering, venture capital, and the C-suite, and the leadership lessons behind scaling Arcellx from an early-stage startup to a $7.8 billion acquisition by Gilead Sciences.

​Attendance is limited. Reserve your spot early.